RA Capital Healthcare Fund LP Net Worth - Insider Trades and Bio as of Jul 8, 2026

MLYSMineralys Therapeutics, Inc.SEC CIK: 0001315082

Estimated Net Worth

$3.05 Billion

Last Updated: May 19, 2026 11:13 PM EST

Transaction Summary

Total Transactions420

Buy-Sell Ratio4.07

Buy Transactions179

Sell Transactions44

Transaction Volume

Total Volume$1.48B

Net Volume$2.40B

Buy Volume$1.94B

Sell Volume-$460.00M

Trade Analysis

AVG Trade Size-$1.45M

Largest Trade$104.71M

Most Active MonthJun

Most Active Year2022

Trading Sentiment

OverallBullish

Recent TradeBuying

Last 90 Days-1 Trades

ConvictionLow

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

RA Capital Healthcare Fund LP has an estimated net worth of $3.05 Billion. This is based on reported shares across multiple companies, which include AN2 Therapeutics, Inc., RHYTHM PHARMACEUTICALS, INC., Vaxcyte, Inc., Dicerna Pharmaceuticals Inc, Eidos Therapeutics, Inc., iTeos Therapeutics, Inc., Mineralys Therapeutics, Inc., Cytek Biosciences, Inc., DICE Therapeutics, Inc., SANGAMO BIOSCIENCES INC, Icosavax, Inc., Tyra Biosciences, Inc., MIRAGEN THERAPEUTICS, INC., RxSight, Inc., Phathom Pharmaceuticals, Inc., TG THERAPEUTICS, INC., Eiger BioPharmaceuticals, Inc., Climb Bio, Inc., KalVista Pharmaceuticals, Inc., Vor Biopharma Inc., Verastem, Inc., Janux Therapeutics, Inc., Aerovate Therapeutics, Inc., Forma Therapeutics Holdings, Inc., Therapeutics Acquisition Corp., G1 Therapeutics, Inc., ARVINAS INC., Synthorx, Inc., CURIS INC, Acumen Pharmaceuticals, Inc., 89bio, Inc., Solid Biosciences Inc., Aclaris Therapeutics, Inc., Iterum Therapeutics plc, Kala Pharmaceuticals, Inc., Orchard Therapeutics plc, Satsuma Pharmaceuticals, Inc., Akouos, Inc., Wave Life Sciences Ltd., Werewolf Therapeutics, Inc., Enliven Therapeutics, Inc., Ra Pharmaceuticals, Inc., Nkarta, Inc., Fulcrum Therapeutics, Inc., scPharmaceuticals Inc., ACHILLION PHARMACEUTICALS INC, ARS Pharmaceuticals, Inc., PepGen Inc., Black Diamond Therapeutics, Inc., DERMA SCIENCES, INC., SEQUENOM INC, BIOSPECIFICS TECHNOLOGIES CORP, Acrivon Therapeutics, Inc., ARADIGM CORP, LIPID SCIENCES INC/, LENZ Therapeutics, Inc., Boundless Bio, Inc., Cidara Therapeutics, Inc., Artiva Biotherapeutics, Inc., Bicara Therapeutics Inc., Septerna, Inc., Sionna Therapeutics, Inc., 4D Molecular Therapeutics, Inc., Evommune, Inc., Adicet Bio, Inc., Hemab Therapeutics Holdings, Inc., Prelude Therapeutics Inc, and SpyGlass Pharma, Inc..

2008 was RA Capital Healthcare Fund LP's most active year for acquiring shares with 337 total transactions. RA Capital Healthcare Fund LP's most active month to acquire stocks was the month of May. 2014 was RA Capital Healthcare Fund LP's most active year for disposing of shares, totalling 164 transactions. RA Capital Healthcare Fund LP's most active month to dispose stocks was the month of August. 2024 saw RA Capital Healthcare Fund LP paying a total of $930,533,893.65 for 139,558,475 shares, this is the most they've acquired in one year. In 2026 RA Capital Healthcare Fund LP cashed out on 15,832,430 shares for a total of $1,080,307,954.80, their largest year based on trade value.

Holdings & Transactions

MLYSmineralys therapeutics, inc.

Updated: Mar 31, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.07	369.00K	$23.75	$8.76M	Mar 31, 2026	7.69M	Purchase	—	Mar 27 - 30	View
From 4	—	14.50K	—	—	Feb 20, 2026	7.34M	Grant	—	Feb 19	View
From 4	0.27	1.18M	$25.50	$30.00M	Sep 08, 2025	7.32M	Purchase	—	Sep 04	View
From 4	0.43	1.30M	$13.50	$17.50M	Mar 17, 2025	6.15M	Purchase	—	Mar 13	View
From 4	—	32.90K	—	—	Feb 24, 2025	32.90K	Grant	—	Feb 13	View
From 4	—	22.00K	—	—	May 28, 2024	22.00K	Grant	—	May 22	View
From 4	1.69	2.22M	$13.50	$30.00M	Feb 14, 2024	5.40M	Grant	—	Feb 12	View
From 4	0.65	1.25M	$16.00	—	Feb 16, 2023	3.18M	Purchase	—	Feb 14	View
From 4	—	44.00K	—	—	Feb 13, 2023	44.00K	Grant	—	Feb 09	View
From 3	—	—	—	—	Feb 09, 2023	—	—	—	—	View

CLYMclimb bio, inc.

Updated: Apr 29, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.10	2.11M	$9.50	$20.01M	Apr 29, 2026	22.55M	Grant	—	Apr 29	View
From 4	0.00	7.11K	$3.50	$24.89K	Jan 07, 2026	11.30M	Purchase	—	Jan 05	View
From 4	0.01	314.56K	$2.40	$754.74K	Dec 15, 2025	31.73M	Purchase	—	Dec 11 - 12	View
From 4	—	40.00K	—	—	Jun 05, 2025	40.00K	Grant	—	Jun 04	View
From 4	0.76	18.27M	$3.84	$49.95M	Jul 01, 2024	44.80M	Purchase	—	Jun 27	View
From 4	—	10.00K	—	—	Jun 28, 2024	10.00K	Grant	—	Jun 26	View
From 4	—	10.00K	—	—	May 22, 2023	10.00K	Grant	—	May 18	View
From 4	—	10.00K	—	—	Jun 01, 2022	10.00K	Grant	—	May 19	View
From 4	0.32	3.20M	$12.50	—	Aug 16, 2021	13.15M	Purchase	—	Aug 12	View
From 4	—	20.00K	—	—	Aug 11, 2021	20.00K	Grant	—	Aug 09	View
From 3	—	—	—	—	Aug 09, 2021	3.08M	—	—	—	View

VORvor biopharma inc.

Updated: Apr 24, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.06	165.15K	$15.77	-$2.60M	Apr 24, 2026	2.40M	Sale	—	Apr 22	View
From 4	-0.20	630.37K	$16.14	-$10.17M	Apr 21, 2026	2.57M	Sale	—	Apr 17 - 20	View
From 4	-0.19	737.99K	$16.10	-$11.88M	Apr 15, 2026	3.20M	Sale	—	Apr 13 - 15	View
From 4	-0.14	620.13K	$16.50	-$10.23M	Apr 10, 2026	3.94M	Sale	—	Apr 08 - 10	View
From 4	-0.16	849.26K	$17.10	-$14.52M	Apr 06, 2026	4.56M	Sale	—	Apr 02 - 06	View
From 4	-0.46	4.62M	$10.81	-$50.00M	Dec 19, 2025	5.41M	Grant	—	Dec 18	View
From 4	-0.34	400.41K	$25.90	-$10.37M	Oct 30, 2025	779.65K	Sale	—	Oct 28 - 30	View
From 4	-0.16	221.17K	$28.06	-$6.20M	Oct 27, 2025	1.18M	Sale	—	Oct 23 - 27	View
From 4	-0.03	117.05K	$29.52	-$3.43M	Oct 22, 2025	4.26M	Sale	—	Oct 20 - 21	View
From 4	-0.03	464.02K	$30.39	-$13.71M	Oct 17, 2025	13.84M	Sale	—	Oct 15 - 17	View
From 4	—	10.00M	$5.00	$50.00M	Sep 22, 2025	10.00M	Grant	—	Sep 18	View
From 4	—	60.00K	—	—	Sep 10, 2025	60.00K	Grant	—	Sep 08	View
From 4	—	30.00K	—	—	May 23, 2025	30.00K	Grant	—	May 22	View
From 4	1.82	38.02M	—	—	Dec 30, 2024	60.77M	Grant	—	Dec 30	View
From 4	—	30.00K	—	—	May 28, 2024	30.00K	Grant	—	May 23	View
From 4	—	30.00K	—	—	Jun 02, 2023	30.00K	Grant	—	May 26	View
From 4	1.25	11.63M	$4.30	$50.00M	Dec 09, 2022	22.75M	Grant	—	Dec 09	View
From 4	—	16.91K	—	—	Jun 17, 2022	16.91K	Grant	—	Jun 14	View
From 4	0.12	998.38K	$43.10	$43.03M	Apr 05, 2021	9.30M	Acquisition	—	Apr 01	View
From 4	-0.82	87.02M	$18.00	$53.63M	Feb 09, 2021	19.21M	Buy-Options	—	Feb 09	View
From 3	—	—	—	—	Feb 04, 2021	—	—	—	—	View

ABOSacumen pharmaceuticals, inc.

Updated: Mar 18, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.46	6.06M	$3.30	$20.00M	Mar 18, 2026	20.99M	Grant	—	Mar 16	View
From 4	—	32.30K	—	—	Jun 05, 2025	14.96M	Grant	—	Jun 04	View
From 4	—	25.00K	—	—	Jun 10, 2024	25.00K	Grant	—	Jun 10	View
From 4	0.65	5.16M	$7.75	$40.00M	Jul 25, 2023	14.93M	Purchase	—	Jul 21	View
From 4	-0.50	25.00K	—	—	Jun 13, 2023	25.00K	Grant	—	Jun 06	View
From 4	—	25.00K	—	—	Jun 21, 2022	25.00K	Grant	—	Jun 15	View
From 4	0.21	1.88M	$16.00	$1.85M	Jul 08, 2021	10.96M	Purchase	—	Jul 06	View
From 3	—	—	—	—	Jun 30, 2021	—	—	—	—	View

WVEwave life sciences ltd.

Updated: Mar 30, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.48	8.77M	$6.23	$54.62M	Mar 30, 2026	27.00M	Purchase	—	Mar 26 - 30	View
From 4	0.00	1.00K	$6.69	$6.69K	Nov 14, 2025	18.23M	Purchase	—	Nov 13	View
From 4	5.52	88.90K	—	—	Aug 13, 2025	18.31M	Grant	—	Aug 11	View
From 4	—	48.34K	—	—	Aug 14, 2024	18.25M	Grant	—	Aug 12	View
From 4/A	0.06	1.00M	$5.00	$5.00M	Jan 17, 2024	18.20M	Purchase	—	Dec 11	View
From 4	0.05	1.00M	$5.00	$5.00M	Dec 13, 2023	19.20M	Purchase	—	Dec 11	View
From 4	—	45.00K	—	—	Aug 09, 2023	45.00K	Grant	—	Aug 07	View
From 4	—	21.00K	—	—	Aug 17, 2022	21.00K	Grant	—	Aug 15	View
From 4	2.15	16.57M	$2.15	$35.63M	Jun 21, 2022	24.30M	Purchase	—	Jun 16	View
From 4	—	42.00K	—	—	Aug 18, 2021	42.00K	Grant	—	Aug 16	View
From 4	0.14	970.02K	$5.61	$5.44M	Apr 05, 2021	7.78M	Acquisition	—	Apr 01	View
From 4	0.75	3.05M	$14.19	$14.50M	Nov 18, 2015	7.09M	Purchase	—	Aug 14 - 16	View
From 3	—	—	—	—	Nov 12, 2015	4.04M	—	—	—	View

HOWLwerewolf therapeutics, inc.

Updated: May 12, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.03	565.17K	$0.67	-$390.69K	May 12, 2026	18.64M	Sale	—	May 08 - 12	View
From 4	0.09	536.43K	$0.91	$487.19K	May 14, 2025	6.68M	Purchase	—	May 12 - 14	View
From 4	—	17.50K	—	—	May 24, 2024	17.50K	Grant	—	May 24	View
From 4	-0.50	13.20K	—	—	Jun 23, 2023	13.20K	Grant	—	Jun 21	View
From 4	0.48	1.85M	$2.21	$4.10M	Jan 10, 2023	6.14M	Purchase	—	Jan 06	View
From 4	—	11.60K	—	—	Jun 03, 2022	11.60K	Grant	—	Jun 01	View
From 4	0.08	323.30K	$12.77	$4.13M	Jun 16, 2021	4.29M	Purchase	—	Jun 14 - 16	View
From 4	-0.80	15.57M	$16.00	—	May 06, 2021	3.97M	Buy-Options	—	May 04	View
From 3	—	—	—	—	Apr 29, 2021	—	—	—	—	View

ACRVacrivon therapeutics, inc.

Updated: Apr 23, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.49	3.89M	$1.80	$7.00M	Apr 23, 2026	12.23M	Grant	—	Apr 22	View
From 4	—	20.27K	—	—	Jun 17, 2025	20.28K	Grant	—	Jun 13	View
From 4	—	20.27K	—	—	Jun 24, 2024	20.28K	Grant	—	Jun 20	View
From 4	0.81	3.53M	$8.50	$30.01M	Apr 15, 2024	8.34M	Grant	—	Apr 11	View
From 4	0.37	1.31M	$12.50	—	Nov 21, 2022	4.81M	Purchase	—	Nov 17	View
From 4	—	35.23K	—	—	Nov 16, 2022	35.24K	Grant	—	Nov 14	View
From 3	—	—	—	—	Nov 09, 2022	—	—	—	—	View

CDTXcidara therapeutics, inc.

Updated: Jan 09, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	4.77M	$110.84	-$1.03B	Jan 09, 2026	—	Options	—	Jan 07	View
From 4	2.08	2.27M	$44.00	$100.00M	Jun 30, 2025	3.37M	Purchase	—	Jun 26	View
From 4	—	5.08K	—	—	Jun 18, 2025	5.08K	Grant	—	Jun 18	View
From 4	—	22.20K	—	—	Jan 07, 2025	22.20K	Grant	—	Jan 03	View
From 4	2.38	1.68M	$14.91	$25.00M	Nov 29, 2024	2.38M	Grant	—	Nov 26	View
From 4	—	793.04K	$1,000.00	$100.00M	Jul 22, 2024	793.04K	Options	—	Jul 18 - 19	View
From 4/A	—	2.13K	—	—	Jul 22, 2024	2.13K	Grant	—	Jul 18	View
From 4	—	2.13K	—	—	Jul 19, 2024	2.13K	Grant	—	Jul 18	View
From 4	—	4.25K	—	—	Apr 30, 2024	4.25K	Grant	—	Apr 26	View
From 3	—	—	—	—	Apr 30, 2024	—	—	—	—	View

ARTVartiva biotherapeutics, inc.

Updated: May 13, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	1.00	8.68M	$11.52	$100.00M	May 13, 2026	18.53M	Purchase	—	May 11	View
From 4	—	13.75K	—	—	Jun 26, 2025	13.75K	Grant	—	Jun 24	View
From 4	2.96	8.80M	$11.10	$104.71M	Jul 24, 2024	11.77M	Purchase	—	Jul 22	View
From 3	—	—	—	—	Jul 18, 2024	—	—	—	—	View

BCAXbicara therapeutics inc.

Updated: Mar 02, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.58	2.50M	$16.00	$40.00M	Mar 02, 2026	9.46M	Purchase	—	Feb 26	View
From 4	—	23.75K	—	—	Jun 10, 2025	23.75K	Grant	—	Jun 09	View
From 4	-0.77	40.40M	$18.00	$32.99M	Sep 18, 2024	12.08M	Buy-Options	—	Sep 16	View
From 4	—	23.75K	—	—	Sep 16, 2024	23.75K	Grant	—	Sep 12	View
From 3	—	—	—	—	Sep 12, 2024	—	—	—	—	View

EVMNevommune, inc.

Updated: Feb 17, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.01	35.87K	$27.88	$1.00M	Feb 17, 2026	3.49M	Grant	—	Feb 17	View
From 3	—	—	—	—	Nov 05, 2025	—	—	—	—	View

ACETadicet bio, inc.

Updated: Apr 29, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Apr 29, 2026	2.34M	Acq/Dis	—	Apr 27	View
From 4	0.23	223.60K	$7.17	$1.60M	Apr 13, 2026	1.18M	Purchase	—	Feb 18 - 20	View
From 3	—	—	—	—	Apr 13, 2026	959.03K	—	—	—	View

COAGhemab therapeutics holdings, inc.

Updated: May 14, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.00	6.39K	$24.90	$159.04K	May 14, 2026	7.74M	Purchase	—	May 12	View
From 4	0.01	51.26K	$24.75	$1.27M	May 11, 2026	7.73M	Purchase	—	May 07 - 11	View
From 4	0.73	7.46M	$20.21	$52.22M	May 06, 2026	17.66M	Purchase	—	May 04 - 06	View
From 3	—	—	—	—	Apr 30, 2026	—	—	—	—	View

PRLDprelude therapeutics inc

Updated: Apr 28, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Apr 28, 2026	7.88M	Acq/Dis	—	Apr 27	View
From 3	—	—	—	—	Apr 28, 2026	7.88M	—	—	—	View

SGPspyglass pharma, inc.

Updated: Feb 11, 2026VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.43	3.69M	$16.00	$59.04M	Feb 11, 2026	12.35M	Purchase	—	Feb 09	View
From 4	—	27.40K	—	—	Feb 09, 2026	27.40K	Grant	—	Feb 05	View
From 3	—	—	—	—	Feb 05, 2026	—	—	—	—	View

TYRAtyra biosciences, inc.

Updated: Jun 16, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.02	163.29K	$10.19	$1.66M	Jun 16, 2025	12.20M	Purchase	—	Jun 12 - 16	View
From 4	0.02	186.85K	$10.19	$1.90M	Jun 11, 2025	12.04M	Purchase	—	Jun 09	View
From 4	0.14	1.21M	$9.70	$11.75M	Jun 06, 2025	11.85M	Purchase	—	Jun 04 - 05	View
From 4	—	22.20K	—	—	Jun 02, 2025	22.20K	Grant	—	May 29	View
From 4	0.16	1.22M	$16.25	$19.84M	Nov 13, 2024	10.64M	Purchase	—	Nov 08	View
From 4	0.19	1.36M	—	—	Oct 22, 2024	10.42M	Acquisition	—	Oct 18	View
From 4	—	18.60K	—	—	May 31, 2024	18.60K	Grant	—	May 29	View
From 4	0.89	4.72M	$13.01	$61.39M	Feb 08, 2024	11.96M	Grant	—	Feb 06	View
From 4	—	14.50K	—	—	Jun 02, 2023	14.50K	Grant	—	May 31	View
From 4	—	14.50K	—	—	Jun 15, 2022	14.50K	Grant	—	Jun 13	View
From 4	2.14	4.93M	$16.00	—	Sep 17, 2021	7.24M	Purchase	—	Sep 17	View
From 3	—	—	—	—	Sep 14, 2021	—	—	—	—	View

JANXjanux therapeutics, inc.

Updated: Jun 13, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	6.17	15.42K	—	—	Jun 13, 2025	11.21M	Grant	—	Jun 11	View
From 4	0.09	824.04K	$30.75	$25.34M	Mar 07, 2025	11.19M	Purchase	—	Mar 05 - 07	View
From 4	0.15	1.20M	$44.75	$53.70M	Oct 22, 2024	10.37M	Purchase	—	Oct 18	View
From 4	—	10.85K	—	—	Jun 28, 2024	9.18M	Grant	—	Jun 26	View
From 4	—	1.40M	$46.50	$65.00M	Mar 06, 2024	1.40M	Purchase	—	Mar 04	View
From 4	0.13	998.23K	$12.46	$12.44M	Jul 21, 2023	9.67M	Purchase	—	Jul 19	View
From 4	—	12.50K	—	—	Jun 16, 2023	12.50K	Grant	—	Jun 14	View
From 4	—	12.50K	—	—	Jun 16, 2022	12.50K	Grant	—	Jun 14	View
From 4	0.94	4.20M	$17.00	—	Jun 16, 2021	8.67M	Purchase	—	Jun 15	View
From 3	—	—	—	—	Jun 10, 2021	—	—	—	—	View

JBIOaerovate therapeutics, inc.

Updated: Apr 30, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	4.71	1.06M	—	—	Apr 30, 2025	1.32M	Acquisition	—	Apr 28	View
From 4	0.13	928.11K	$1.67	$1.55M	Jun 20, 2024	9.19M	Purchase	—	Jun 17	View
From 4	—	12.50K	—	—	Jun 07, 2024	12.50K	Grant	—	Jun 05	View
From 4	—	12.50K	—	—	Jun 08, 2023	12.50K	Grant	—	Jun 06	View
From 4	—	12.50K	—	—	Jun 22, 2022	12.50K	Grant	—	Jun 21	View
From 4	-0.50	8.24M	$14.00	—	Jul 06, 2021	8.26M	Buy-Options	—	Jul 02	View
From 3	—	—	—	—	Jun 29, 2021	241.47K	—	—	—	View

ETNB89bio, inc.

Updated: Nov 03, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	24.40M	—	—	Nov 03, 2025	—	Disposition	—	Oct 30	View
From 4	—	56.40K	—	—	Feb 05, 2025	56.40K	Grant	—	Feb 03	View
From 4	0.41	5.71M	$8.75	$50.00M	Feb 03, 2025	19.89M	Purchase	—	Jan 30	View
From 4	3.01	3.25M	$8.50	$27.62M	Nov 18, 2024	4.33M	Purchase	—	Nov 14	View
From 4	-0.09	1.34M	$5.33	$7.50M	Apr 15, 2024	14.25M	Options	—	Feb 09 - 11	View
From 4	0.12	1.35M	$15.35	$20.72M	Mar 06, 2024	12.77M	Purchase	—	Mar 04	View
From 4	—	1.08M	$9.25	$10.00M	Dec 13, 2023	1.08M	Purchase	—	Dec 11	View
From 4	0.29	2.46M	$16.25	$40.00M	Mar 30, 2023	11.42M	Purchase	—	Mar 24	View
From 4	0.15	1.17M	$7.65	$8.97M	Oct 20, 2022	8.96M	Purchase	—	Oct 18	View
From 4	1.58	5.63M	$3.55	$10.00M	Jul 06, 2022	9.19M	Purchase	—	Jul 01	View
From 4	—	25.00K	—	—	Jun 02, 2022	25.00K	Grant	—	May 16	View
From 4	0.00	22.14K	$18.77	$415.53K	Jun 04, 2021	4.97M	Purchase	—	Jun 02	View
From 4	0.04	207.42K	$18.60	$3.86M	May 28, 2021	4.94M	Purchase	—	May 26 - 28	View
From 4	0.17	628.28K	$23.68	$14.88M	Apr 05, 2021	4.74M	Acquisition	—	Apr 01	View
From 4	0.38	1.30M	$28.00	$36.40M	Sep 21, 2020	4.74M	Purchase	—	Sep 17	View
From 4	0.09	275.00K	$27.50	$7.56M	Jul 10, 2020	3.44M	Purchase	—	Jul 08	View
From 4	-0.69	7.17M	$16.00	—	Nov 13, 2019	3.16M	Buy-Options	—	Nov 11 - 13	View
From 3	—	—	—	—	Nov 08, 2019	—	—	—	—	View

SLDBsolid biosciences inc.

Updated: Feb 21, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	3.72M	$4.03	$15.00M	Feb 21, 2025	3.72M	Purchase	—	Feb 19	View
From 4	0.27	904.16K	$5.53	$5.00M	Jan 12, 2024	4.30M	Purchase	—	Jan 11	View
From 4	—	9.65K	—	—	Jun 08, 2023	9.65K	Grant	—	Jun 06	View
From 4	—	9.65K	—	—	Dec 15, 2022	9.65K	Grant	—	Dec 13	View
From 4	3.12	2.57M	$7.05	—	Dec 05, 2022	3.40M	Grant	—	Dec 02	View
From 4	—	51.00K	—	—	Jun 09, 2022	51.00K	Grant	—	Jun 07	View
From 4	0.13	1.45M	$5.53	$8.03M	Apr 05, 2021	12.37M	Acquisition	—	Apr 01	View
From 4	0.25	2.21M	$5.75	$12.69M	Mar 23, 2021	10.92M	Purchase	—	Mar 19	View
From 3	—	—	—	—	Dec 15, 2020	8.71M	—	—	—	View

NKTXnkarta, inc.

Updated: Jun 09, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	46.00K	—	—	Jun 09, 2025	46.00K	Grant	—	Jun 05	View
From 4	—	22.50K	—	—	Jun 14, 2024	22.50K	Grant	—	Jun 13	View
From 4	0.85	6.00M	$10.00	$60.00M	Mar 29, 2024	13.81M	Purchase	—	Mar 27	View
From 4	—	22.50K	—	—	Jun 09, 2023	22.50K	Grant	—	Jun 07	View
From 4	—	16.00K	—	—	Jun 10, 2022	16.00K	Grant	—	Jun 08	View
From 4	0.39	2.20M	$15.00	$33.00M	Apr 28, 2022	7.81M	Purchase	—	Apr 26	View
From 4	0.13	568.03K	$32.90	$18.69M	Apr 05, 2021	5.61M	Acquisition	—	Apr 01	View

FULCfulcrum therapeutics, inc.

Updated: Dec 10, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.41	4.18M	$13.98	-$58.38M	Dec 10, 2025	6.05M	Sale	—	Dec 08	View
From 3	—	—	—	—	Sep 23, 2024	10.23M	—	—	—	View
From 4	—	—	—	—	Aug 23, 2024	11.61M	Acq/Dis	—	Aug 21	View
From 4	0.20	1.92M	$13.00	$25.00M	Jan 24, 2023	11.61M	Purchase	—	Jan 20	View
From 4	0.02	180.70K	$7.28	$1.31M	Jan 06, 2023	9.69M	Purchase	—	Jan 04	View
From 4	0.00	4.09K	$5.99	$24.51K	Dec 29, 2022	9.51M	Purchase	—	Dec 27	View
From 4	0.01	98.79K	$5.90	$582.81K	Dec 21, 2022	9.50M	Purchase	—	Dec 19	View
From 4	0.34	2.40M	$5.44	$13.07M	Dec 16, 2022	9.40M	Purchase	—	Dec 14 - 16	View
From 3	—	—	—	—	Aug 26, 2022	7.00M	—	—	—	View

SPRYars pharmaceuticals, inc.

Updated: Jun 27, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	30.00K	—	—	Jun 27, 2025	30.00K	Grant	—	Jun 25	View
From 4	—	40.00K	—	—	Jun 24, 2024	40.00K	Grant	—	Jun 20	View
From 4	0.16	1.40M	$9.48	$13.29M	Mar 27, 2024	10.86M	Purchase	—	Mar 25 - 27	View
From 4	0.46	2.70M	$3.03	$8.18M	Sep 25, 2023	9.46M	Purchase	—	Sep 21	View
From 4	1.78	3.75M	$6.20	$23.25M	Aug 31, 2023	6.76M	Purchase	—	Aug 29	View
From 4	—	40.00K	—	—	Jun 28, 2023	40.00K	Grant	—	Jun 27	View
From 4	—	3.01M	—	—	Nov 10, 2022	3.01M	Grant	—	Nov 08	View
From 3	—	—	—	—	Nov 10, 2022	—	—	—	—	View

PEPGpepgen inc.

Updated: Sep 30, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	1.02	9.38M	$3.20	$30.00M	Sep 30, 2025	20.06M	Purchase	—	Sep 26	View
From 4	—	16.00K	—	—	Jun 06, 2025	16.00K	Grant	—	Jun 04	View
From 4	—	13.00K	—	—	Jun 21, 2024	13.00K	Grant	—	Jun 20	View
From 4	0.39	2.56M	$10.64	$27.21M	Feb 13, 2024	10.69M	Purchase	—	Feb 09	View
From 4	0.63	3.14M	$12.00	—	May 12, 2022	8.13M	Purchase	—	May 10	View
From 3/A	—	—	—	—	May 12, 2022	—	—	—	—	View
From 4	—	11.67K	—	—	May 10, 2022	11.67K	Grant	—	May 06	View
From 3	—	—	—	—	May 05, 2022	—	—	—	—	View

LENZlenz therapeutics, inc.

Updated: Jun 11, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	13.50K	—	—	Jun 11, 2025	13.50K	Grant	—	Jun 11	View
From 4	1.44	4.34M	$15.03	$15.00M	Mar 25, 2024	7.36M	Purchase	—	Mar 21	View
From 3	—	—	—	—	Mar 25, 2024	—	—	—	—	View

SEPNsepterna, inc.

Updated: Jun 20, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	16.62K	—	—	Jun 20, 2025	16.62K	Grant	—	Jun 17	View
From 4	-0.64	17.34M	$18.00	$75.06M	Oct 30, 2024	9.82M	Buy-Options	—	Oct 28	View
From 3	—	—	—	—	Oct 24, 2024	—	—	—	—	View

SIONsionna therapeutics, inc.

Updated: Nov 24, 2025VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.00	30.32K	$39.96	-$1.20M	Nov 24, 2025	29.77M	Sale	—	Nov 20 - 21	View
From 4	-0.00	136.35K	$40.59	-$5.50M	Nov 19, 2025	59.86M	Sale	—	Nov 17 - 19	View
From 4	-0.02	373.61K	$39.54	-$14.76M	Oct 28, 2025	20.21M	Sale	—	Oct 24 - 28	View
From 4	—	19.96K	—	—	Jun 16, 2025	19.96K	Grant	—	Jun 12	View
From 4	-0.12	2.54M	$18.00	$20.25M	Feb 10, 2025	18.57M	Buy-Options	—	Feb 10	View
From 3	—	—	—	—	Feb 06, 2025	1.37M	—	—	—	View

ANTXan2 therapeutics, inc.

Updated: Aug 13, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.64	3.53M	$1.08	-$3.81M	Aug 13, 2024	2.03M	Sale	—	Aug 09	View
From 4	0.53	1.78M	$9.00	$16.00M	Aug 22, 2023	5.55M	Purchase	—	Aug 18	View
From 4	0.00	1.91K	$7.74	$14.33K	Aug 05, 2022	7.55M	Purchase	—	Aug 03 - 04	View
From 4	0.01	23.22K	$7.78	$180.67K	Jul 28, 2022	3.77M	Purchase	—	Jul 26 - 27	View
From 4	0.00	302.00	$7.99	$2.41K	Jun 23, 2022	3.75M	Purchase	—	Jun 21	View
From 4	0.02	81.42K	$7.95	$647.40K	Jun 15, 2022	3.75M	Purchase	—	Jun 13 - 14	View
From 4	0.83	1.67M	$15.00	—	Mar 31, 2022	3.67M	Purchase	—	Mar 29	View
From 3	—	—	—	—	Mar 24, 2022	—	—	—	—	View

ITOSiteos therapeutics, inc.

Updated: May 14, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	1.66	5.71M	$17.50	—	May 14, 2024	10.13M	Purchase	—	May 10 - 12	View
From 4	—	17.54K	—	—	Jun 10, 2022	17.54K	Grant	—	Jun 09	View
From 4	0.14	421.21K	$34.18	$14.40M	Apr 05, 2021	4.42M	Acquisition	—	Apr 01	View

ICVXicosavax, inc.

Updated: Feb 20, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	6.01M	—	—	Feb 20, 2024	—	Disposition	—	Feb 19	View
From 4	—	17.00K	—	—	Jun 08, 2023	17.00K	Grant	—	Jun 06	View
From 4	—	27.82K	—	—	Jun 14, 2022	5.99M	Grant	—	Jun 10	View
From 4	0.02	184.22K	$4.64	$836.88K	Mar 30, 2022	11.92M	Purchase	—	Mar 28 - 29	View
From 4	-0.55	7.16M	$15.00	—	Aug 04, 2021	5.78M	Buy-Options	—	Aug 02	View
From 3	—	—	—	—	Jul 28, 2021	—	—	—	—	View

boundless bio, inc.

Updated: Apr 04, 2024

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.94	34.25M	$16.00	—	Apr 04, 2024	2.18M	Buy-Options	—	Apr 02	View
From 3	—	—	—	—	Mar 27, 2024	—	—	—	—	View

FDMT4d molecular therapeutics, inc.

Updated: Dec 10, 2024VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	—	—	—	Dec 10, 2024	8.17M	Acq/Dis	—	Dec 09	View
From 3	—	—	—	—	Nov 25, 2024	5.10M	—	—	—	View

dice therapeutics, inc.

Updated: Aug 09, 2023

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	7.88M	—	—	Aug 09, 2023	—	Disposition	—	Aug 09	View
From 4	0.08	509.14K	$29.07	$14.80M	Mar 30, 2023	7.86M	Purchase	—	Mar 28 - 30	View
From 4	0.08	498.56K	$26.99	$13.46M	Mar 27, 2023	7.35M	Purchase	—	Mar 23 - 27	View
From 4	0.31	1.64M	$36.50	$59.86M	Oct 19, 2022	6.85M	Purchase	—	Oct 17	View
From 4	—	21.25K	—	—	Jun 08, 2022	21.25K	Grant	—	Jun 07	View
From 4	0.37	1.40M	$17.00	—	Sep 20, 2021	5.21M	Purchase	—	Sep 17	View
From 3	—	—	—	—	Sep 14, 2021	—	—	—	—	View

satsuma pharmaceuticals, inc.

Updated: Jun 12, 2023

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	5.97M	—	—	Jun 12, 2023	—	Disposition	—	Jun 08	View
From 4	—	30.00K	—	—	Jun 07, 2022	30.00K	Grant	—	Jun 03	View
From 4	0.15	758.40K	$5.91	$4.48M	Apr 05, 2021	5.91M	Acquisition	—	Apr 01	View
From 4	0.31	1.23M	$5.68	$7.00M	Mar 02, 2021	5.16M	Purchase	—	Feb 26	View
From 4	—	20.00K	—	—	Dec 07, 2020	20.00K	Grant	—	Dec 03	View
From 4	0.40	1.33M	$15.00	—	Sep 17, 2019	4.68M	Purchase	—	Sep 17	View
From 3	—	—	—	—	Sep 12, 2019	—	—	—	—	View

ELVNenliven therapeutics, inc.

Updated: Feb 27, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	1.19	1.15M	—	—	Feb 27, 2023	2.12M	Grant	—	Feb 23	View
From 4	0.19	629.30K	$4.00	$2.52M	Jan 05, 2023	3.88M	Purchase	—	Jan 03	View
From 4	0.01	29.90K	$3.87	$115.60K	Dec 12, 2022	3.25M	Purchase	—	Dec 08 - 09	View
From 4	0.03	85.90K	$3.92	$336.81K	Oct 24, 2022	3.22M	Purchase	—	Oct 20 - 24	View
From 4	0.19	506.20K	$3.68	$1.86M	Oct 19, 2022	3.13M	Purchase	—	Oct 17 - 19	View
From 3	—	—	—	—	Oct 19, 2022	2.63M	—	—	—	View
From 4	-0.16	287.01K	$16.00	—	Mar 17, 2020	1.45M	Buy-Options	—	Mar 16	View
From 3	—	—	—	—	Mar 11, 2020	—	—	—	—	View

BDTXblack diamond therapeutics, inc.

Updated: Jul 07, 2023VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.41	935.85K	$5.00	$4.68M	Jul 07, 2023	3.53M	Purchase	—	Jul 05	View

CTKBcytek biosciences, inc.

Updated: Mar 16, 2022VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.05	583.87K	$12.31	$7.19M	Mar 16, 2022	13.38M	Purchase	Scheduled	Mar 14 - 15	View
From 4	0.05	634.64K	$12.86	$8.16M	Mar 11, 2022	12.80M	Purchase	Scheduled	Mar 09 - 11	View
From 4	0.06	647.26K	$12.74	$8.25M	Mar 08, 2022	12.16M	Purchase	Scheduled	Mar 04 - 08	View
From 4	0.04	441.87K	$12.95	$5.72M	Mar 02, 2022	11.52M	Purchase	Scheduled	Feb 28 - 02	View
From 4	0.04	420.38K	$13.23	$5.56M	Feb 25, 2022	11.07M	Purchase	Scheduled	Feb 23 - 25	View
From 4	0.05	547.38K	$14.06	$7.70M	Feb 22, 2022	10.65M	Purchase	Scheduled	Feb 17 - 22	View
From 4	0.05	498.63K	$14.89	$7.43M	Feb 16, 2022	10.11M	Purchase	Scheduled	Feb 14 - 16	View
From 4	0.44	2.95M	$17.00	—	Jul 29, 2021	9.61M	Purchase	—	Jul 27	View
From 3	—	—	—	—	Jul 22, 2021	—	—	—	—	View

forma therapeutics holdings, inc.

Updated: Oct 14, 2022

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	9.05M	—	—	Oct 14, 2022	—	Disposition	—	Oct 14	View
From 4	4.09	11.25K	—	—	Jun 09, 2022	9.03M	Grant	—	Jun 08	View
From 4	0.08	542.02K	$28.02	$15.19M	Apr 05, 2021	9.01M	Acquisition	—	Apr 01	View
From 4	-0.58	12.43M	$20.00	—	Jun 24, 2020	9.01M	Buy-Options	—	Jun 23	View
From 3	—	—	—	—	Jun 18, 2020	—	—	—	—	View

KALAkala pharmaceuticals, inc.

Updated: May 26, 2022VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.13	1.01M	$0.36	-$365.67K	May 26, 2022	7.04M	Sale	—	May 26	View
From 4	-0.26	2.83M	$0.53	-$1.49M	May 25, 2022	8.05M	Sale	—	May 23 - 25	View
From 4	0.18	1.69M	$6.74	$11.38M	Apr 05, 2021	10.87M	Acquisition	—	Apr 01	View
From 4	1.40	6.34M	$7.89	$50.00M	Mar 13, 2020	10.87M	Purchase	—	Mar 13	View
From 4	1.15	2.42M	$8.25	$20.00M	Oct 05, 2018	4.54M	Purchase	—	Oct 03	View
From 4	-0.74	6.12M	$15.00	—	Jul 26, 2017	2.11M	Buy-Options	—	Jul 25	View
From 3	—	—	—	—	Jul 19, 2017	—	—	—	—	View

RXSTrxsight, inc.

Updated: Aug 13, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Aug 13, 2021	3.05M	—	—	—	View

PHATphathom pharmaceuticals, inc.

Updated: Mar 15, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.19	710.00K	$43.75	-$31.06M	Mar 15, 2021	3.12M	Sale	—	Mar 11	View
From 4	0.03	117.60K	$24.86	$2.92M	Apr 03, 2020	3.83M	Purchase	—	Apr 01	View
From 4	0.02	60.60K	$24.58	$1.49M	Mar 31, 2020	3.71M	Purchase	—	Mar 27 - 31	View
From 3/A	—	—	—	—	Feb 06, 2020	3.65M	—	—	—	View
From 3	—	—	—	—	Nov 04, 2019	3.65M	—	—	—	View

PNTtherapeutics acquisition corp.

Updated: Jun 30, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.24	209.10K	$10.00	$2.09M	Jun 30, 2021	1.10M	Purchase	—	Jun 29	View
From 3	—	—	—	—	Jun 24, 2021	889.22K	—	—	—	View

ITRMiterum therapeutics plc

Updated: Feb 08, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.37	3.17M	—	—	Feb 08, 2021	11.65M	Options	—	Feb 04	View
From 3	—	—	—	—	Dec 02, 2020	—	—	—	—	View

ORTXorchard therapeutics plc

Updated: Feb 11, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	3.22M	$6.22	$20.00M	Feb 11, 2021	3.22M	Purchase	—	Feb 09	View
From 4	0.08	769.02K	$4.63	$3.56M	Nov 06, 2020	9.88M	Purchase	—	Aug 10 - 24	View
From 3	—	—	—	—	Nov 06, 2020	9.11M	—	—	—	View

SCPHscpharmaceuticals inc.

Updated: Mar 16, 2021VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.05	150.06K	$7.08	-$1.06M	Mar 16, 2021	2.73M	Sale	—	Mar 12 - 15	View
From 4/A	0.08	271.99K	$8.20	$2.23M	Feb 21, 2020	3.52M	Purchase	—	Feb 14	View
From 4	0.09	271.99K	$8.20	$2.23M	Feb 19, 2020	3.25M	Purchase	—	Feb 14	View
From 4	0.14	389.86K	$2.70	$1.05M	Apr 15, 2019	3.25M	Purchase	—	Apr 11	View

RYTMrhythm pharmaceuticals, inc.

Updated: Dec 04, 2020VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.05	238.54K	$29.47	-$7.03M	Dec 04, 2020	4.36M	Sale	—	Dec 02 - 03	View
From 4	-0.02	131.58K	$22.06	-$2.90M	Jul 02, 2020	5.14M	Sale	—	Jun 30 - 02	View
From 4	-0.03	150.32K	$23.05	-$3.47M	Jun 29, 2020	5.27M	Sale	—	Jun 25 - 29	View
From 3	—	—	—	—	Oct 18, 2019	5.42M	—	—	—	View

PCVXvaxcyte, inc.

Updated: Oct 09, 2020VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.05	266.26K	$50.78	-$13.52M	Oct 09, 2020	5.00M	Sale	—	Oct 07 - 08	View
From 4	-0.04	221.33K	$49.81	-$11.25M	Oct 01, 2020	5.39M	Sale	—	Sep 29 - 01	View
From 3	—	—	—	—	Jun 18, 2020	5.49M	—	—	—	View

VRDNmiragen therapeutics, inc.

Updated: Dec 17, 2020VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Dec 17, 2020	410.69K	—	—	—	View

TGTXtg therapeutics, inc.

Updated: May 07, 2020VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	May 07, 2020	12.79M	—	—	—	View

VSTMverastem, inc.

Updated: Jun 29, 2020VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.07	1.16M	$1.91	-$2.22M	Jun 29, 2020	16.14M	Sale	—	Jun 25	View
From 4	-0.07	1.30M	$2.31	-$3.00M	Apr 29, 2020	17.30M	Sale	—	Apr 27	View
From 3	—	—	—	—	Mar 05, 2020	18.60M	—	—	—	View

synthorx, inc.

Updated: Jan 24, 2020

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4/A	-1.00	9.72M	$68.00	-$661.27M	Jan 24, 2020	—	Disposition	—	Jan 23	View
From 4	-1.00	9.72M	$68.00	-$661.27M	Jan 24, 2020	—	Disposition	—	Jan 23	View
From 4	0.17	1.43M	$11.00	—	Dec 13, 2018	9.72M	Purchase	—	Dec 11	View
From 3	—	—	—	—	Dec 06, 2018	—	—	—	—	View

akouos, inc.

Updated: Jul 02, 2020

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.93	28.41M	$17.00	—	Jul 02, 2020	2.28M	Buy-Options	—	Jun 30	View
From 3	—	—	—	—	Jun 25, 2020	—	—	—	—	View

ra pharmaceuticals, inc.

Updated: Apr 03, 2020

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-1.00	4.86M	$48.00	-$233.20M	Apr 03, 2020	—	Disposition	—	Apr 02	View
From 4	—	15.00K	—	—	Jun 13, 2019	15.00K	Grant	—	Jun 11	View
From 4	0.26	1.01M	$15.50	$15.60M	Dec 14, 2018	4.86M	Purchase	—	Dec 12	View
From 4	—	15.00K	—	—	Nov 01, 2018	15.00K	Grant	—	Jun 28	View
From 4	—	15.00K	—	—	Jul 02, 2018	15.00K	Grant	—	Jun 28	View
From 4	1.85	2.50M	$6.00	$15.00M	Feb 16, 2018	3.85M	Purchase	—	Feb 14	View
From 4	-0.73	6.98M	$13.00	$2.10M	Oct 31, 2016	2.54M	Buy-Options	—	Oct 31	View
From 3	—	—	—	—	Oct 25, 2016	—	—	—	—	View

eidos therapeutics, inc.

Updated: Jun 22, 2018

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	1.34	1.24M	$17.00	—	Jun 22, 2018	2.16M	Purchase	—	Jun 22	View
From 3	—	—	—	—	Jun 19, 2018	—	—	—	—	View

EIGReiger biopharmaceuticals, inc.

Updated: Oct 25, 2018VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 3	—	—	—	—	Oct 25, 2018	2.42M	—	—	—	View

ARVNarvinas inc.

Updated: Oct 03, 2018VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.55	3.81M	$16.00	—	Oct 03, 2018	3.14M	Buy-Options	—	Oct 01	View
From 3	—	—	—	—	Sep 26, 2018	—	—	—	—	View

dicerna pharmaceuticals inc

Updated: Dec 20, 2017

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	1.03	2.57M	$3.19	-$244.03K	Dec 20, 2017	5.07M	Options	—	Dec 18	View
From 4	—	76.50K	$100.00	$7.65M	Apr 13, 2017	76.50K	Acq/Dis	—	Apr 11	View
From 4	—	25.00K	—	—	Apr 21, 2014	25.00K	Grant	—	Apr 16	View
From 4	0.70	1.00M	$15.00	—	Feb 05, 2014	2.43M	Purchase	—	Feb 04	View
From 3	—	—	—	—	Jan 29, 2014	—	—	—	—	View

GTHXg1 therapeutics, inc.

Updated: May 24, 2017VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.46	4.17M	$8.61	-$6.50M	May 24, 2017	4.97M	Buy-Options	—	May 22	View
From 3	—	—	—	—	May 16, 2017	—	—	—	—	View

KALVkalvista pharmaceuticals, inc.

Updated: Nov 23, 2016VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	—	591.07K	—	—	Nov 23, 2016	591.07K	Grant	—	Nov 21	View
From 3	—	—	—	—	Nov 23, 2016	—	—	—	—	View

ACRSaclaris therapeutics, inc.

Updated: Sep 19, 2016VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.20	525.55K	$24.19	-$12.71M	Sep 19, 2016	2.10M	Sale	—	Sep 15 - 16	View
From 4	0.02	39.73K	$17.15	$681.47K	Feb 24, 2016	2.63M	Purchase	—	Feb 22 - 23	View
From 4	0.00	7.80K	$19.87	$155.07K	Jan 20, 2016	2.59M	Purchase	—	Jan 15 - 20	View
From 4	0.01	15.64K	$19.10	$298.74K	Jan 13, 2016	2.58M	Purchase	—	Jan 11 - 13	View
From 4	0.11	244.20K	$14.00	$3.42M	Oct 30, 2015	2.56M	Purchase	—	Oct 28 - 29	View
From 4	0.00	5.41K	$14.03	$75.88K	Oct 26, 2015	2.32M	Purchase	—	Oct 22	View

SGMOsangamo biosciences inc

Updated: Feb 18, 2015VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.35	1.00M	$13.31	-$14.44M	Feb 18, 2015	1.83M	Sale	—	Jun 05 - 01	View
From 4	-0.41	1.99M	$12.64	-$26.31M	Feb 18, 2015	2.83M	Sale	—	May 07 - 05	View
From 4	0.19	755.04K	$14.86	$10.91M	Feb 18, 2015	4.82M	Purchase	—	Apr 03 - 07	View
From 4	0.01	593.62K	$22.40	$11.11M	Feb 18, 2015	40.90M	Purchase	—	Mar 06 - 01	View
From 4	-0.01	242.52K	$13.20	-$5.01M	Feb 18, 2015	22.13M	Sale	—	Jan 29 - 06	View
From 4	-0.01	57.80K	$15.22	-$1.15M	Feb 18, 2015	3.97M	Sale	—	Dec 12 - 09	View
From 4	-0.04	798.24K	$9.88	-$7.81M	Feb 18, 2015	21.18M	Sale	—	Jul 17 - 25	View
From 3	—	—	—	—	Feb 18, 2015	3.68M	—	—	—	View
From 3	—	—	—	—	Feb 18, 2015	4.03M	—	—	—	View
From 3	—	—	—	—	Feb 18, 2015	3.63M	—	—	—	View

achillion pharmaceuticals inc

Updated: Jan 20, 2015

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	0.02	1.60M	$5.61	$3.79M	Jan 20, 2015	71.46M	Purchase	—	Sep 16 - 30	View
From 4	0.00	498.26K	$4.14	$3.29M	Jan 20, 2015	138.97M	Purchase	—	Jul 15 - 26	View
From 3/A	—	—	—	—	Jan 20, 2015	6.84M	—	—	—	View
From 4	-0.17	1.33M	$10.20	-$13.59M	Oct 01, 2014	6.70M	Sale	—	Sep 29 - 30	View
From 4	-0.23	2.37M	$11.17	-$26.50M	Sep 26, 2014	8.03M	Sale	—	Sep 24 - 26	View
From 4	-0.20	2.60M	$11.29	-$29.30M	Sep 23, 2014	10.40M	Sale	—	Sep 19 - 23	View
From 4/A	-0.12	1.70M	$12.45	-$21.22M	Sep 12, 2014	13.00M	Sale	—	Sep 10 - 11	View
From 4	-0.12	1.70M	$10.49	-$17.88M	Sep 12, 2014	13.00M	Sale	—	Sep 10 - 11	View
From 4	-0.05	835.29K	$11.63	-$9.71M	Sep 02, 2014	14.70M	Sale	—	Aug 28 - 02	View
From 4	-0.15	2.71M	$11.33	-$30.71M	Aug 27, 2014	15.54M	Sale	—	Aug 25 - 27	View
From 4	—	—	$0.16	$11.20K	Aug 22, 2014	35.00K	Purchase	—	Oct 01	View
From 3/A	—	—	—	—	Aug 22, 2014	11.66M	—	—	—	View
From 4	-0.19	4.24M	$9.53	-$40.35M	Aug 19, 2014	18.25M	Sale	—	Aug 15 - 18	View
From 4	0.05	1.11M	$2.55	$2.83M	Nov 22, 2013	23.37M	Purchase	—	Nov 20	View
From 4	0.06	1.19M	$2.45	$2.90M	Nov 01, 2013	20.46M	Purchase	—	Oct 31	View
From 4	0.14	2.37M	$2.79	$6.62M	Oct 16, 2013	19.28M	Purchase	—	Oct 14	View
From 4	0.05	2.45M	$2.57	$6.28M	Oct 15, 2013	48.38M	Purchase	—	Oct 11	View
From 4	0.24	2.80M	$2.98	$8.35M	Oct 04, 2013	14.46M	Purchase	—	Sep 30	View
From 3	—	—	—	—	Oct 04, 2013	11.66M	—	—	—	View

derma sciences, inc.

Updated: Jan 13, 2014

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.15	300.00K	$11.83	-$3.55M	Jan 13, 2014	1.69M	Sale	—	Jan 10	View
From 4	0.00	3.94K	$11.40	$44.97K	May 01, 2013	1.99M	Purchase	—	Apr 29	View
From 3	—	—	—	—	May 01, 2013	1.99M	—	—	—	View

biospecifics technologies corp

Updated: Feb 26, 2010

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.02	10.00K	$28.83	-$288.30K	Feb 26, 2010	626.46K	Sale	—	Feb 26	View
From 4	-0.03	22.31K	$29.02	-$647.49K	Feb 24, 2010	636.46K	Sale	—	Feb 22 - 23	View
From 4	-0.07	50.00K	$29.05	-$1.45M	Feb 19, 2010	658.77K	Sale	—	Feb 17	View
From 4	-0.16	132.83K	$28.80	-$3.83M	Feb 08, 2010	708.77K	Sale	—	Feb 03	View
From 4	0.02	15.76K	$19.45	$306.54K	May 11, 2009	841.60K	Purchase	—	Apr 24 - 28	View
From 4	0.00	1.18K	$18.39	$21.78K	Apr 24, 2009	825.84K	Purchase	—	Apr 13 - 14	View
From 4	0.01	9.72K	$18.66	$181.38K	Apr 14, 2009	824.66K	Purchase	—	Apr 08 - 09	View
From 4	0.00	4.01K	$18.80	$75.38K	Apr 07, 2009	814.94K	Purchase	—	Apr 01 - 02	View
From 4	0.01	10.85K	$19.08	$206.95K	Mar 19, 2009	810.93K	Purchase	—	Mar 13 - 17	View
From 4	0.01	4.65K	$18.55	$86.24K	Mar 12, 2009	800.09K	Purchase	—	Mar 10 - 11	View
From 4	0.01	5.39K	$21.63	$116.61K	Jan 07, 2009	795.44K	Purchase	—	Dec 31	View
From 4	0.01	9.70K	$21.86	$212.08K	Dec 31, 2008	790.05K	Purchase	—	Dec 29	View
From 4	0.01	6.20K	$20.27	$125.69K	Dec 31, 2008	780.35K	Purchase	—	Dec 22 - 23	View
From 4	0.01	31.95K	$20.08	$596.77K	Dec 18, 2008	2.30M	Grant	—	Dec 16 - 18	View
From 4	0.06	44.89K	$16.68	$748.81K	Nov 21, 2008	742.20K	Purchase	—	Nov 17 - 18	View
From 4	0.07	48.47K	$16.38	$793.64K	Nov 14, 2008	697.31K	Purchase	—	Nov 12 - 14	View
From 4	0.00	500.00	$16.00	$8.00K	Nov 07, 2008	648.84K	Purchase	—	Nov 05	View
From 4	0.02	11.90K	$14.47	$172.24K	Nov 04, 2008	648.34K	Purchase	—	Oct 30 - 03	View
From 4	0.01	6.90K	$15.83	$109.23K	Oct 08, 2008	636.44K	Purchase	—	Oct 06 - 07	View
From 4	0.02	14.20K	$18.49	$262.45K	Sep 26, 2008	629.54K	Purchase	—	Sep 25	View
From 3	—	—	—	—	Sep 26, 2008	615.35K	—	—	—	View

CRIScuris inc

Updated: Apr 17, 2008VIEW QUOTE

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.17	1.30M	$1.40	-$1.82M	Apr 17, 2008	6.25M	Sale	—	Apr 15	View
From 3/A	—	—	—	—	Feb 27, 2008	7.55M	—	—	—	View
From 3	—	—	—	—	Aug 15, 2007	7.52M	—	—	—	View

sequenom inc

Updated: Jul 15, 2008

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4/A	—	10.00K	$378.88	$3.79M	Jul 15, 2008	10.00K	Purchase	—	Jun 25	View
From 4	—	8.26K	$409.62	$3.58M	Jul 14, 2008	5.88M	Purchase	—	Jul 10 - 11	View
From 4	0.00	19.27K	$16.14	$310.97K	Jun 27, 2008	5.88M	Purchase	—	Jun 25	View
From 4	0.06	341.57K	$15.50	$5.29M	Jun 27, 2008	5.86M	Purchase	—	Jun 25	View
From 4	0.00	33.42K	$15.09	$501.63K	Jun 27, 2008	16.53M	Purchase	—	Jun 25	View
From 4	0.01	35.75K	$9.13	$410.57K	Jun 27, 2008	5.49M	Purchase	—	Jun 25	View
From 4	0.03	183.60K	$12.18	$2.24M	Jun 13, 2008	5.45M	Purchase	—	Jun 10	View
From 4	0.04	208.12K	$12.92	$2.69M	Jun 13, 2008	5.06M	Purchase	—	Jun 09	View
From 4	0.00	59.83K	$12.56	$753.84K	Jun 13, 2008	28.93M	Purchase	—	Jun 09	View
From 4	0.03	126.70K	$12.09	$1.53M	Jun 13, 2008	4.79M	Purchase	—	Jun 09	View
From 4	0.01	32.40K	$11.90	$385.58K	Jun 13, 2008	4.66M	Purchase	—	Jun 09	View
From 4	0.00	11.60K	$11.75	$136.30K	Jun 13, 2008	4.63M	Purchase	—	Jun 06	View
From 3	—	—	—	—	Jun 13, 2008	4.62M	—	—	—	View

aradigm corp

Updated: Oct 31, 2008

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.84	5.60M	$0.25	-$1.40M	Oct 31, 2008	1.08M	Sale	—	Oct 29	View
From 4	-0.13	1.00M	$0.35	-$350.00K	Oct 08, 2008	6.68M	Sale	—	Oct 06	View
From 4	0.03	191.60K	$1.36	$259.76K	Jan 16, 2008	7.68M	Purchase	—	Jan 15	View
From 4	0.09	635.00K	$1.40	$889.00K	Nov 05, 2007	7.49M	Purchase	—	Nov 01	View
From 4	0.02	110.80K	$1.38	$152.90K	Sep 13, 2007	6.85M	Purchase	—	Sep 13	View
From 4	0.05	300.00K	$1.40	$420.00K	Sep 13, 2007	6.74M	Purchase	—	Sep 11	View
From 3	—	—	—	—	Feb 05, 2007	6.36M	—	—	—	View

lipid sciences inc/

Updated: Mar 31, 2008

Form Type	Δ Own, %	Traded Shares	Price	Size, $	Filing Date	Own, %	Type	Scheduled	Trade Dates	SEC Filing
From 4	-0.00	8.65K	$1.30	-$11.24K	Mar 31, 2008	3.71M	p	—	Mar 27	View
From 3	—	—	—	—	Mar 28, 2007	3.71M	—	—	—	View
From 4	-0.03	100.60K	$1.46	-$146.54K	Dec 29, 2006	3.66M	Sale	—	Dec 21	View
From 3	—	—	—	—	Dec 29, 2006	3.76M	—	—	—	View

Benzinga

Benzinga

Net Worth & Trading Activity Over Time

Monthly Trading Pattern

Past Insider Trading and Trends

Holdings & Transactions